Neonatal vitamin D status and risk of multiple sclerosis: A population-based case-control study
- PMID: 27903815
- PMCID: PMC5200855
- DOI: 10.1212/WNL.0000000000003454
Neonatal vitamin D status and risk of multiple sclerosis: A population-based case-control study
Abstract
Objective: As previous research has suggested that exposure to vitamin D insufficiency in utero may have relevance for the risk of multiple sclerosis (MS), we aimed to examine the direct association between level of neonatal vitamin D and risk of MS.
Methods: We carried out a matched case-control study. Dried blood spots samples (DBSS) belonging to 521 patients with MS were identified in the Danish Newborn Screening Biobank. For every patient with MS, 1-2 controls with the same sex and birth date were retrieved from the Biobank (n = 972). Level of 25-hydroxyvitamin D (25[OH]D) in the DBSS was measured using liquid chromatography tandem mass spectroscopy. The association between different levels of 25(OH)D and risk of MS was evaluated by odds ratios (OR) calculated in conditional logistic regression models.
Results: We observed that lower levels of 25(OH)D in neonates were associated with an increased risk of MS. In the analysis by quintiles, MS risk was highest among individuals in the bottom quintile (<20.7 nmol/L) and lowest among those in the top quintile of 25(OH)D (≥48.9 nmol/L), with an OR for top vs bottom of 0.53 (95% confidence interval [CI] 0.36-0.78). In the analysis treating 25(OH)D as a continuous variable, a 25 nmol/L increase in neonatal 25(OH)D resulted in a 30% reduced risk of MS (OR 0.70, 95% CI 0.57-0.84).
Conclusion: Low concentrations of neonatal vitamin D are associated with an increased risk of MS. In light of the high prevalence of vitamin D insufficiency among pregnant women, our observation may have importance for public health.
© 2016 American Academy of Neurology.
Figures
Comment in
-
A gestational dose of vitamin D per day keeps the MS doctor away.Neurology. 2017 Jan 3;88(1):13-14. doi: 10.1212/WNL.0000000000003469. Epub 2016 Nov 30. Neurology. 2017. PMID: 27903816 No abstract available.
-
Letter re: Neonatal vitamin D status and risk of multiple sclerosis: A population-based case-control study.Neurology. 2017 Jul 25;89(4):410. doi: 10.1212/WNL.0000000000004138. Neurology. 2017. PMID: 28739664 No abstract available.
-
Letter re: Neonatal vitamin D status and risk of multiple sclerosis: A population-based case-control study.Neurology. 2017 Jul 25;89(4):410-411. doi: 10.1212/WNL.0000000000004139. Neurology. 2017. PMID: 28739665 No abstract available.
-
Author response: Neonatal vitamin D status and risk of multiple sclerosis: A population-based case-control study.Neurology. 2017 Jul 25;89(4):411. doi: 10.1212/WNL.0000000000004140. Neurology. 2017. PMID: 28739666 No abstract available.
References
-
- Word Health Organization. Neurological Disorders: Public Health Challenges. Geneva: Word Health Organization; 2006:85–95.
-
- Koch-Henriksen N, Sorensen PS. The changing demographic pattern of multiple sclerosis epidemiology. Lancet Neurol 2010;9:520–532. - PubMed
-
- Salzer J, Hallmans G, Nystrom M, Stenlund H, Wadell G, Sundstrom P. Vitamin D as a protective factor in multiple sclerosis. Neurology 2012;79:2140–2145. - PubMed
-
- Munger KL, Levin LI, Hollis BW, Howard NS, Ascherio A. Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis. JAMA 2006;296:2832–2838. - PubMed
-
- Munger KL, Zhang SM, O'Reilly E, et al. . Vitamin D intake and incidence of multiple sclerosis. Neurology 2004;62:60–65. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials